<!DOCTYPE html><html prefix="og: http://ogp.me/ns#" lang="zh">
<!-- Mirrored from cn.nytimes.com/business/20141212/c12chinahealth/zh-hant/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:13:01 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head><meta charset="UTF-8"><!-- Browser render  --><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="renderer" content="webkit"><!-- End Browser render --><meta name="keywords" content=""><meta name="description" content="中國醫療體系腐敗叢生風險巨大，但老齡化使中國醫療市場潛力巨大。各國私募股權機構、醫藥企業紛紛前來投資，料將推動中國醫改。"><meta id="uuid" name="uuid" content="de1e2f7eff8717fdcd18d5d021e3d195"><meta id="headline" name="headline" content="風險與潛力並存，國際資本注入中國醫療行業 - 紐約時報中文網"><meta id="byline" name="byline" content="NEIL GOUGH"><meta id="date" name="date" content="2014-12-12T08:31:01.000Z"><link rel="alternate" href="../index.html" hreflang="zh-Hans"><link rel="alternate" href="index.html" hreflang="zh-Hant"><link rel="canonical" href="index.html"><link rel="alternate" type="application/rss+xml" href="https://cn.nytimes.com/rss/zh-hant/"><meta name="apple-itunes-app" content="app-id=807498298, app-argument=nytimescn://article:de1e2f7eff8717fdcd18d5d021e3d195"><meta name="lang" property="lang" content="zh-cmn-hant"><!-- Apple IOS safari private meta --><link rel="apple-touch-icon-precomposed" sizes="144×144" href="../../../../../static01.nyt.com/images/icons/ios-ipad-144x144.png"><link rel="apple-touch-icon-precomposed" sizes="114×114" href="../../../../../static01.nyt.com/images/icons/ios-iphone-114x144.png"><link rel="apple-touch-icon-precomposed" href="../../../../../static01.nyt.com/images/icons/ios-default-homescreen-57x57.png"><meta name="apple-mobile-web-app-title" content="風險與潛力並存，國際資本注入中國醫療行業 - 紐約時報中文網"><meta name="apple-mobile-web-app-capable" content="yes"><!-- End Apple IOS safari private meta --><!-- Viewport and mobile --><meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no,maximum-scale=1,minimum-scale=1,minimal-ui"><!-- End viewport and mobile --><meta http-equiv="Cache-Control" content="no-siteapp"><meta name="format-detection" content="telephone=no"><meta name="HandheldFriendly" content="true"><meta name="MobileOptimized" content="320"><meta name="x5-orientation" content="portrait"><meta name="full-screen" content="yes"><meta name="x5-fullscreen" content="true"><meta name="browsermode" content="application"><meta name="x5-page-mode" content="app"><meta name="msapplication-tap-highlight" content="no"><meta property="og:title" content="風險與潛力並存，國際資本注入中國醫療行業"><meta property="og:type" content="article"><meta property="og:url" content="index.html"><meta property="og:description" content="中國醫療體系腐敗叢生風險巨大，但老齡化使中國醫療市場潛力巨大。各國私募股權機構、醫藥企業紛紛前來投資，料將推動中國醫改。"><meta property="og:site_name" content="紐約時報中文網"><meta property="article:publisher" content="https://www.facebook.com/nytimeschinese"><meta property="article:published_time" content="2014-12-12T08:31:01.000Z"><meta property="fb:pages" content="1504603339831430"><meta property="fb:app_id" content="853699254762608"><meta property="og:image" content="../../../../../static01.nyt.com/images/2014/12/11/business/dealbook/11ASIA/11-ASIA-articleLarge.html"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:url" content="index.html"><meta property="twitter:title" content="風險與潛力並存，國際資本注入中國醫療行業"><meta property="twitter:description" content="中國醫療體系腐敗叢生風險巨大，但老齡化使中國醫療市場潛力巨大。各國私募股權機構、醫藥企業紛紛前來投資，料將推動中國醫改。"><meta property="twitter:domain" content="cn.nytimes.com"><meta property="twitter:site" content="@nytchinese"><meta property="twitter:creator" content="@nytchinese"><meta property="twitter:image:src" content="../../../../../static01.nyt.com/images/2014/12/11/business/dealbook/11ASIA/11-ASIA-articleLarge.html"><meta name="PT" content="article"><meta name="PST" content="News"><meta name="CG" content="business"><meta name="SCG" content=""><meta name="sourceApp" content="nyt-china-web"><meta name="ptime" content="20141212083101"><meta name="utime" content="20141212083101"><meta name="pdate" content="20141212"><meta name="dat" content="Dec. 12, 2014"><meta name="hdl" content="風險與潛力並存，國際資本注入中國醫療行業"><meta name="byl" content="NEIL GOUGH"><meta name="lp" content="中國醫療體系腐敗叢生風險巨大，但老齡化使中國醫療市場潛力巨大。各國私募股權機構、醫藥企業紛紛前來投資，料將推動中國醫改。"><link rel="shortcut icon" href="https://static01.nyt.com/favicon.ico"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/style-flex.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/web/style.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/article.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/slideshow/slideshow.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/cookie-banner/style.min619b.css?v=f1810d8"><title>風險與潛力並存，國際資本注入中國醫療行業 - 紐約時報中文網</title></head><script>var js_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/js";
 var imgs_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style/imgs";
 var style_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style";
 var site = 1;
 var sectionName = "business";
 var adTyp = "art";
 var cookieString = {
     "title": "您的追蹤器設置",
     "headline": "我們使用 cookie 做什麼？",
     "summary": '<p>我們利用cookies和類似的技術識別您的重複訪問和偏好。我們還使用它們來衡量廣告系列的效果，定位廣告並分析和網站流量。更多關於cookies的資訊（包括如何停用），<a href="https://www.nytimes.com/zh-hant/privacy/cookie-policy" rel="noreferrer noopener" target="_blank" data-testid="GDPR-policy">請查看我們的「Cookie政策」</a>。</span><span>自2020年7月20日起，我們將根據您在我們服務中所訪問的內容類型向您顯示我們認為與您的興趣相關的廣告。您可以<a href="https://www.nytimes.com/zh-hant/privacy/cookie-policy#how-do-i-manage-trackers" rel="noreferrer noopener" target="_blank" data-testid="GDPR-objection">提出反對</a>。希望了解更多信息，請參見我們的<a href="https://nytimes.com/zh-hant/privacy/privacy-policy#we-allow-for-personalized-advertising-on-times-services" rel="noreferrer noopener" target="_blank" data-testid="GDPR-privacy">隱私政策</a>。</p><p>透過在此處點擊「我接受」或者「X」， 您將被視為同意使用cookies。您隨時可以通過我們的Cookie政策來更改您的跟踪器偏好。</p>',
     "button": "接受",
     "trackerButton": "您的追蹤器設置",
     "rejectButton": "拒絕所有",
     "lang": 'zh-hant',
     "trackerLink": "https://www.nytimes.com/zh-hant/privacy/cookie-policy",
 };
 var purrString = {
     "button": "請勿出售我的個人資訊",
     "snackbar": "你的設定已經保存在此瀏覽器和設備上。如果你清除了 cookie，這些設定也會被清除。",
     "snackbarError": "Something went wrong",
     "optedOutText": "我们不再出售您的個人資訊",
     "CFALinkText": "California Notices",
     "purrPopupTitle": "Your request to not sell your data will be stored for this browser and device",
     "purrPopupSummary": "If you clear your cookies, your preference will be forgotten. As a California resident, you have additional rights under the California Consumer Privacy Act of 2018. While The New York Times Company does not “sell” personal information of its readers as the term “sell” is traditionally understood, “sell” under the CCPA is broadly defined. To learn more, review the text below.",
     "purrPopupButton": "DISMISS",
     "purrPopupScrollContent": 'ssa sed. Nec sagittis aliquam malesuada bibendum arcu. Nunc sed blandit libero volutpat sed cras ornare arcu. Metus vulputate eu scelerisque felis imperdiet proin. Elit eget gravida cum sociis natoque penatibus. Sodales ut eu sem integer. Vitae auctor eu augue ut lectus arcu bibendum at. Vulputate ut pharetra sit amet aliquam id diam. Eu tincidunt tortor aliquam nulla facilisi cras fermentum odio eu. Imperdiet dui accumsan sit amet nulla facilisi morbi. Laoreet non curabitur gravida arcu ac tortor dignissim. Magna fringilla urna porttitor rhoncus dolor purus. In nulla posuere sollicitudin aliquam. At elementum eu facilisis sed odio. Diam in arcu cursus euismod quis viverra. Viverra suspendisse potenti nullam ac tortor vitae purus. Felis donec et odio pellentesque diam volutpat. Lacus sed turpis tincidunt id aliquet risus feugiat in.Aliquam ut porttitor leo a diam sollicitudin tempor',
     "lang": 'zh-hant'
 };
 cbSectionName = "business";
 cbByline = "NEIL GOUGH";</script><!-- Google Tag Manager --><script>(function(w,d,s,l,i){
     w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});
     var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
     j.async=true;j.src='../../../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;
     f.parentNode.insertBefore(j,f);
 })(window,document,'script','dataLayer','GTM-KTDZV8V');</script><!-- End Google Tag Manager --><!-- chartbeat --><script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script><!-- /chartbeat --><body class="news"><main class="container-fluid main clearfix"><header class="row title-bar"><div class="nav-button default" id="menuBtn"><i class="icon-bars"></i></div><h1 class="logo"><a href="/"><svg role="img" aria-label="" width="90%" height="90%"><image width="100%" height="100%" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hant.svg" src="../../../../../d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hant%402x.png" alt="" border="0"></image></svg></a></h1><div class="nav-button default" id="gearBtn"><i class="icon-gear"></i></div><div class="popup gear-popup"><div class="tips-container"><div class="tips-border"></div><div class="tips-inner"></div></div><div class="popup-container"><div class="popup-body"><div class="setting-title">簡繁中文</div><div class="setting-option"><a href="../index024e.html?changeLang=zh-hans">簡體 </a><a href="../index27d8.html?changeLang=zh-hant" class="active">繁體</a></div><div class="setting-title">紐約時報 出版語言</div><ul class="menu-list"><li><a href="https://www.nytimes.com/">ENGLISH (英語)</a></li><li><a href="https://www.nytimes.com/es/">ESPAÑOL (西班牙語)</a></li></ul><div class="setting-title">字體大小</div><div class="setting-option"><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="small"> 小</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="normal" checked="checked"> 中</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="large"> 大</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="xlarge"> 超大</label></div></div></div></div></div></header><div class="top_banner_ad" id="topad" data-target="{&quot;pos&quot;:&quot;top&quot;,&quot;adv&quot;:&quot;&quot;}"></div><div class="article-area"><div class="setting-bar row"><div class="col-4 section-title"><h3>商業與經濟</h3></div><div class="col-8 setting-btns"><div class="row"><div class="col-6"><ul class="dual-btn"><li><a href="javascript:;" class="active"><span class="setting-btn-text">中文</span> <span class="setting-btn-text-mobile">中</span></a></li><li><a href="dual/index.html"><span class="setting-btn-text">中英雙語</span> <span class="setting-btn-text-mobile">雙語</span></a></li><li><a href="#" target="_blank"><span class="setting-btn-text">英文 <i class="icon-share-square"></i> </span><span class="setting-btn-text-mobile">英</span></a></li></ul></div><div class="col-6 share-tools-top-container"><ul class="share-tools mobile-article"><li><a href="http://v.t.sina.com.cn/share/share.php?&amp;title=%E9%A2%A8%E9%9A%AA%E8%88%87%E6%BD%9B%E5%8A%9B%E4%B8%A6%E5%AD%98%EF%BC%8C%E5%9C%8B%E9%9A%9B%E8%B3%87%E6%9C%AC%E6%B3%A8%E5%85%A5%E4%B8%AD%E5%9C%8B%E9%86%AB%E7%99%82%E8%A1%8C%E6%A5%AD&amp;url=https://cn.nytimes.com/business/20141212/c12chinahealth/zh-hant/" target="_blank"><i class="icon-weibo"></i></a></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20141212/c12chinahealth/zh-hant/" data-headline="%E9%A2%A8%E9%9A%AA%E8%88%87%E6%BD%9B%E5%8A%9B%E4%B8%A6%E5%AD%98%EF%BC%8C%E5%9C%8B%E9%9A%9B%E8%B3%87%E6%9C%AC%E6%B3%A8%E5%85%A5%E4%B8%AD%E5%9C%8B%E9%86%AB%E7%99%82%E8%A1%8C%E6%A5%AD"> --><!-- <i class="icon-wechat"></i> --><!-- </a> --><!-- </li> --><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://cn.nytimes.com/business/20141212/c12chinahealth/zh-hant/" trage="_blank"><i class="icon-facebook"></i></a></li><li><a href="https://plus.google.com/share?url=https://cn.nytimes.com/business/20141212/c12chinahealth/zh-hant/" target="_blank"><i class="icon-google"></i></a></li><li><a href="https://twitter.com/share?text=%E9%A2%A8%E9%9A%AA%E8%88%87%E6%BD%9B%E5%8A%9B%E4%B8%A6%E5%AD%98%EF%BC%8C%E5%9C%8B%E9%9A%9B%E8%B3%87%E6%9C%AC%E6%B3%A8%E5%85%A5%E4%B8%AD%E5%9C%8B%E9%86%AB%E7%99%82%E8%A1%8C%E6%A5%AD&amp;url=https://cn.nytimes.com/business/20141212/c12chinahealth/zh-hant/" target="_blank"><i class="icon-twitter"></i></a></li><li><div class="line-it-button" data-lang="zh_Hant" data-type="share-g" data-url="https://cn.nytimes.com/business/20141212/c12chinahealth/zh-hant/" style="display: none;"></div><script src="/d.line-scdn.net/r/web/social-plugin/js/thirdparty/loader.min.js" async="async" defer="defer"></script></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20141212/c12chinahealth/zh-hant/" data-headline="%E9%A2%A8%E9%9A%AA%E8%88%87%E6%BD%9B%E5%8A%9B%E4%B8%A6%E5%AD%98%EF%BC%8C%E5%9C%8B%E9%9A%9B%E8%B3%87%E6%9C%AC%E6%B3%A8%E5%85%A5%E4%B8%AD%E5%9C%8B%E9%86%AB%E7%99%82%E8%A1%8C%E6%A5%AD"> --><!-- <i class="icon-qrcode"></i> --><!-- </a> --><!-- </li> --></ul><div class="share-btn"><i class="icon-forward"></i></div></div></div></div></div><article class="article-content font-normal"><div class="article-header"><header><small>交易錄</small><h1>風險與潛力並存，國際資本注入中國醫療行業</h1></header><div class="byline-row"><div class="byline-box"><div class="byline"><address>NEIL GOUGH</address><time pudate="2014-12-12 08:31:01" datetime="2014-12-12 08:31:01">2014年12月12日</time></div><div class="share-btn"><i class="icon-forward"></i></div></div></div></div><figure class="article-span-photo"><img src="../../../../../static01.nyt.com/images/2014/12/11/business/dealbook/11ASIA/11-ASIA-master1050.html" width="1050" height="700" alt="上海的一家醫院。人們對更多更優質的醫療產品和服務的需求正不斷增長。"><figcaption><span>上海的一家醫院。人們對更多更優質的醫療產品和服務的需求正不斷增長。</span> <cite>Aly Song/Reuters</cite></figcaption></figure><div class="row"><div class="article-left"><section class="article-body"><div class="article-partial"><div class="article-body-item col-lg-5"><div class="article-paragraph">香港——膽小的人不適合投資中國醫療行業。</div><div class="article-paragraph">中國的藥品供應鏈腐敗橫生；患者因被拒診而襲擊醫生和醫院工作人員；沒錢進行手術截肢的農民，因為鋸斷自己的腿腳而登上新聞頭條。</div><div class="article-paragraph">儘管如此，對於尋求下一個尚未被開發的巨大市場的投資者來說，中國的醫療行業正在迅速成為最受歡迎的領域之一。國內外的私募股權機構、醫藥公司、醫院運營商乃至建築公司，都在將創紀錄的巨額資金注入中國，投資醫院、診所、製藥公司和醫療設備製造商。Dealogic的數據顯示，今年前11個月，中國醫療行業的併購金額增至創紀錄的113億美元（約合700億元人民幣），較去年同期的100億美元提高13%。</div><div class="article-paragraph">儘管中國的醫療體系面臨諸多挑戰，但對於更多、更好的醫療產品和服務的需求正在快速增長。這既有人口結構方面的原因，也有經濟方面的原因：作為全世界人口最多的國家，中國在迅速老齡化的同時，民眾也越來越富裕。諮詢公司麥肯錫(McKinsey & Company)預測，到2020年，中國的醫療支出將從2011年略高於3500億美元的水平，提高到1萬億美元。</div><div class="article-paragraph">「我們已經開始注意到，各類通常不涉足醫療領域的參與者，也變得很感興趣——他們可以看到人口數據顯示出的趨勢，即人口老齡化，」普華永道(PricewaterhouseCoopers)駐上海的中國醫療和生命科學業務負責人馬克·吉爾布雷斯(Mark Gilbraith)說。「在中國，交易所涉及的更多是獲得渠道，進入未被開發的市場。」</div><div class="article-paragraph">交易達成的數量和投資者興趣的激增，與中國政府近年推行的廣泛改革浪潮同時出現。中國的醫療體系廣泛被指處於危機狀態，中國政府試圖通過改革來解決看病難、看病貴的問題。儘管近幾十年來，中國經濟的開放程度大幅提升，但由於社會主義式的國家資助出現減少，中國醫療體系只得自謀生路。結果便造就了部分自由化、卻高度官僚化的公立醫院體系。這一體系常常為了獲利而損害對病患的照顧。</div><div class="article-paragraph">今年4月，官方通訊社新華社報道，截至2013年10月，中國有13440家公立醫院，佔據着中國醫療服務市場90%的份額。</div><div class="article-paragraph">「不同於世界上的大部分公立醫院，中國的公立醫院既體現了政府的失敗，也體現了市場的失敗，」牛津大學布拉瓦尼克政府學院(Blavatnik School of Government)的葉志敏教授(Winnie Yip)和哈佛大學公共衛生學院(Harvard School of Public Health)的蕭慶倫教授(William Hsiao)在合撰的一篇文章中寫道。文章於今年8月發表在英國醫學期刊《柳葉刀》(The Lancet)上。</div><div class="article-paragraph">儘管政府規定，醫院對藥品的加價不能超過15%，但醫生可以通過開不必要的藥品，或是不需要的昂貴診斷檢查來增加收入。此外，這兩位教授還寫道，製藥企業和醫療設備製造商會向使用其產品的醫院和醫生提供好處。</div><div class="article-paragraph">因此，2011年，中國在藥品上的支出佔到了全部醫療支出的43%，相比之下，經濟合作與發展組織(Organization for Economic Cooperation and Development)數十個發達國家的平均比例為16%。與此同時，藥品收入在中國醫院總收入中的比重達41%。</div><div class="article-paragraph">「許多公立機構的行為方式與私營機構無異，把盈利置於患者的福利之上，」葉教授和蕭教授寫道。</div><div class="article-paragraph">最近幾年，中國政府已經設法讓基本醫療保險覆蓋所有居民。官方的數據顯示，覆蓋率已超過90%。但中國各地醫療保險的質量參差不齊，個人享受醫療服務的便利性也差異巨大。</div><div class="article-paragraph">這些差異在最近的新聞報道中得到了生動的展示，比如安徽省農民劉敦和的例子。由於沒有保險也沒錢做手術，劉敦和決定自己動手。4月20日夜裡，他在六個小時的過程中，鋸掉了因為凍傷而嚴重壞死的雙腳。</div><div class="article-paragraph">醫療衛生體系普遍存在的腐敗行為，尤其是涉及藥品處方的腐敗行為，也是一個問題。它已經讓一些跨國投資者蒙受損失。9月，醫藥巨頭葛蘭素史克(GlaxoSmithKline)因行賄被中國一家法院<a href="../../../20140921/c21glaxo/index.html" title="Link: http://cn.nytimes.com/business/20140921/c21glaxo/">處以近5億美元的罰款</a>，該公司的五名高管被判刑，包括一名英國人。官方指控葛蘭素史克向醫院和醫生行賄，通過旅行社和製藥行業協會輸送回扣，提高藥品價格。</div><div class="article-paragraph">中國政府越來越擔心醫療體系的種種問題，其中一個解決辦法是進一步放開該領域的外國投資。最近的例子是，今年8月，當局擴大了一個月前開始的一個試點項目，允許純外資醫院在幾個主要的城市和省份經營。之前，醫院的外資持股上限是70%。</div><div class="article-paragraph">這種開放措施在近期促成了多筆交易。今年9月，美國私募股權巨頭德州太平洋集團(TPG)與中國大型投資公司復星集團(Fosun Group)的一家子公司合作達成了一筆4.2億美元的交易，對納斯達克上市的美中互利工業公司(Chindex International Inc.)實施了私有化。該公司在中國和蒙古國經營着一些醫院和診所。</div><div class="article-paragraph">不久前，匹茲堡的醫院經營企業UPMC，以及哈佛大學(Harvard University)附屬的馬薩諸塞州綜合醫院(Massachusetts General Hospital)都透露，它們要麼已經簽約在中國管理或建設醫院，要麼正在尋求這方面的合作。</div><div class="article-paragraph">紐約的對外關係委員會(Council on Foreign Relations)專註於全球醫療衛生的高級研究員黃延中說，「投資中國的醫療領域會遇到許多挑戰。」他提到，需要付出大量資本、回報率相對較低，此外私有的醫院如何納入中國的全國性醫療支付系統也存在不確定性。</div><div class="article-paragraph">他說，不過，更多私人投資會令整個行業受益，包括處境艱難的公立醫院。</div><div class="article-paragraph">「競爭壓力的加劇會刺激公立醫院開展更有意義的改革措施，」黃延中說，「私人投資在中國的醫療改革中可以起到重要、甚至關鍵性的作用。」</div></div><div class="article-body-aside col-lg-3"></div></div></section><footer class="author-info"><p>翻譯：陳亦亭、王湛</p></footer></div></div></article><div class="container article-footer"><div class="row"><div class="col-lg-12 mobile-refer-cont" id="J_hideRefer"><div class="related-cont"><h4>相關報導</h4><ul class="refer-list"><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20141104/c04driveby/zh-hant/" title="醫療賬單上，隱藏的收費防不勝防"><div><h3 class="refer-list-headline">醫療賬單上，隱藏的收費防不勝防</h3><p class="refer-pubdate">2014年11月4日</p></div><img alt="醫療賬單上，隱藏的收費防不勝防" src="../../../../../static01.nyt.com/images/2014/09/21/us/21driveby-kaufman/21driveby-kaufman-thumbLarge.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../20140921/c21glaxo/zh-hant/index.html" title="葛蘭素史克因在華行賄被罰30億"><div><h3 class="refer-list-headline">葛蘭素史克因在華行賄被罰30億</h3><p class="refer-pubdate">2014年9月21日</p></div><img alt="葛蘭素史克因在華行賄被罰30億" src="../../../../../static01.nyt.com/images/2014/09/20/business/20glaxo-cnd/20glaxo-cnd-thumbLarge.jpg" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../20140810/c10glaxo/zh-hant/index.html" title="葛蘭素史克商業偵探在華被判監禁"><div><h3 class="refer-list-headline">葛蘭素史克商業偵探在華被判監禁</h3><p class="refer-pubdate">2014年8月10日</p></div><img alt="葛蘭素史克商業偵探在華被判監禁" src="../../../../../static01.nyt.com/images/2014/08/09/business/Glaxo1/Glaxo1-thumbLarge.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/opinion/20140226/c26krugman/zh-hant/" title="共和黨找不到醫療改革失敗的例證"><div><h3 class="refer-list-headline">共和黨找不到醫療改革失敗的例證</h3><p class="refer-pubdate">2014年2月26日</p></div><img alt="共和黨找不到醫療改革失敗的例證" src="../../../../../static01.nyt.com/images/2010/09/16/opinion/Krugman_New/Krugman_New-thumbLarge.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20130515/c15doctor/zh-hant/" title="中美醫療差距在哪裡？"><div><h3 class="refer-list-headline">中美醫療差距在哪裡？</h3><p class="refer-pubdate">2013年5月15日</p></div></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20130510/cc10yuying/zh-hant/" title="醫院該怎樣減少醫療差錯"><div><h3 class="refer-list-headline">醫院該怎樣減少醫療差錯</h3><p class="refer-pubdate">2013年5月10日</p></div></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/health/20130314/cc14yuying/zh-hant/" title="醫療糾紛背後的故事"><div><h3 class="refer-list-headline">醫療糾紛背後的故事</h3><p class="refer-pubdate">2013年3月14日</p></div></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../20120706/c06norris/zh-hant/index.html" title="中國醫療技術股價玄機"><div><h3 class="refer-list-headline">中國醫療技術股價玄機</h3><p class="refer-pubdate">2012年7月6日</p></div></a></div></li></ul></div></div><div class="col-lg-12"><div class="related hot_article"><h5 class="related-title">最受歡迎</h5><ol class="related-articles"><li><a href="#https://cn.nytimes.com/opinion/20220127/pakistan-united-states-china/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>「巴鐵」軍方為什麼想與中國保持距離？</h4><img alt="「巴鐵」軍方為什麼想與中國保持距離？" src="../../../../../static01.nyt.com/images/2022/01/24/opinion/21Rafiq1/21Rafiq1-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220127/computer-chip-shortage-taiwan/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>戰棋推演報告稱台灣半導體工廠停產可能引發中美衝突</h4><img alt="戰棋推演報告稱台灣半導體工廠停產可能引發中美衝突" src="../../../../../static01.nyt.com/images/2022/01/26/us/politics/26dc-wargames/merlin_177315390_5fcf8532-e370-4f81-8f99-45c6c83044f4-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220126/china-covid-19/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>中國追求「清零」將把國家置於災難之中</h4><img alt="中國追求「清零」將把國家置於災難之中" src="../../../../../static01.nyt.com/images/2022/01/25/opinion/25emanuel/25emanuel-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/sports/20220127/peng-shuai-china-australian-open/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>澳網再現「彭帥在哪裡」：球員和觀賽者拒絕遺忘、為其發聲</h4><img alt="澳網再現「彭帥在哪裡」：球員和觀賽者拒絕遺忘、為其發聲" src="../../../../../static01.nyt.com/images/2022/01/26/sports/26aus-china1/merlin_199503951_9c695f25-2b8e-41b4-9c97-bf91de7aa190-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220125/gang-chen-mit-china/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>「我們在殘害我們自己」：華裔教授陳剛案背後的憤怒與幻滅</h4><img alt="「我們在殘害我們自己」：華裔教授陳剛案背後的憤怒與幻滅" src="../../../../../static01.nyt.com/images/2022/01/24/science/24CHEN-promo/24CHEN-promo-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/virtual-reality-simulation/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>你可以開始相信，我們有可能會活在虛擬現實裡</h4><img alt="你可以開始相信，我們有可能會活在虛擬現實裡" src="../../../../../static01.nyt.com/images/2022/01/26/opinion/26manjoo-image/26manjoo-image-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/winter-olympics-china-beijing-xi-jinping/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>不再取悅世界：一屆展現習近平全面願景的冬奧會</h4><img alt="不再取悅世界：一屆展現習近平全面願景的冬奧會" src="../../../../../static01.nyt.com/images/2022/01/13/world/00xi-olympics-30/00xi-olympics-30-thumbLarge.jpg"></article></a></li><li><a href="../../../20220126/imf-world-economic-report/zh-hant/indexf61c.html?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>國際貨幣基金組織稱中美經濟放緩將拖累全球經濟</h4><img alt="國際貨幣基金組織稱中美經濟放緩將拖累全球經濟" src="../../../../../static01.nyt.com/images/2022/01/25/multimedia/25global-econ-brf/25global-econ-brf-thumbLarge-v2.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/asia-pacific/20220126/north-korea-launches-missiles-kim/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>朝鮮突然頻繁試射導彈傳遞了什麼信息？</h4><img alt="朝鮮突然頻繁試射導彈傳遞了什麼信息？" src="../../../../../static01.nyt.com/images/2022/01/21/world/00nkorea-gameplan-01/00nkorea-gameplan-01-thumbLarge.html"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/china-zero-covid-policy/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>多地封鎖引發沮喪與抱怨，中國「清零」政策還能走多遠？</h4><img alt="多地封鎖引發沮喪與抱怨，中國「清零」政策還能走多遠？" src="../../../../../static01.nyt.com/images/2022/01/20/world/00virus-china-lockdown-01/00virus-china-lockdown-01-thumbLarge.html"></article></a></li></ol></div></div></div></div></div><footer class="row copy-footer">&copy; 2022 The World Economy Observer.<ul class="footerLinkList"><li class="footerLink"><a rel="nofollow" href="/ad/">广告</a></li><li class="footerLink"><a rel="nofollow" href="/about-us/">关于我们</a></li><li class="footerLink"><a rel="nofollow" href="/contact/">联系我们</a></li><li class="footerLink"><a rel="nofollow" href="/tos/">服务条款</a></li><li class="purr-content"></li></ul></footer><script src="/d1f1eryiqyjs0r.cloudfront.net/js/libs/require619b.js?v=f1810d8"></script><script src="/d1f1eryiqyjs0r.cloudfront.net/js/web/article.min619b.js?v=f1810d8"></script></main></body>
<!-- Mirrored from cn.nytimes.com/business/20141212/c12chinahealth/zh-hant/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:13:01 GMT -->
</html>